During the past decade, Centrym Medyczne AMED oddzial w Lodzi conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centrym Medyczne AMED oddzial w Lodzi" are "Lupus Erythematosus, Systemic" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Centrym Medyczne AMED oddzial w Lodzi" in a lesser frequency.

Most popular intervention types in "Centrym Medyczne AMED oddzial w Lodzi" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daxdilimab" (1 trials), "Placebo" (1 trials) and "VIB7734" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrym Medyczne AMED oddzial w Lodzi" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centrym Medyczne AMED oddzial w Lodzi". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Centrym Medyczne AMED oddzial w Lodzi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrym Medyczne AMED oddzial w Lodzi, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".